nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—metabolic syndrome X	0.629	1	CbGaD
Aminosalicylic Acid—Taste metallic—Metformin—metabolic syndrome X	0.00836	0.228	CcSEcCtD
Aminosalicylic Acid—MPO—artery—metabolic syndrome X	0.00796	0.102	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—metabolic syndrome X	0.00672	0.0859	CbGeAlD
Aminosalicylic Acid—MPO—blood vessel—metabolic syndrome X	0.0062	0.0792	CbGeAlD
Aminosalicylic Acid—CHUK—cardiovascular system—metabolic syndrome X	0.0058	0.0742	CbGeAlD
Aminosalicylic Acid—Abdominal bloating—Metformin—metabolic syndrome X	0.00559	0.152	CcSEcCtD
Aminosalicylic Acid—CHUK—adipose tissue—metabolic syndrome X	0.00512	0.0654	CbGeAlD
Aminosalicylic Acid—PTGS1—artery—metabolic syndrome X	0.00378	0.0483	CbGeAlD
Aminosalicylic Acid—PTGS2—artery—metabolic syndrome X	0.00361	0.0461	CbGeAlD
Aminosalicylic Acid—CHUK—liver—metabolic syndrome X	0.00359	0.0459	CbGeAlD
Aminosalicylic Acid—ALOX5—cardiovascular system—metabolic syndrome X	0.00327	0.0418	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—metabolic syndrome X	0.00319	0.0408	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—metabolic syndrome X	0.00305	0.039	CbGeAlD
Aminosalicylic Acid—PTGS1—blood vessel—metabolic syndrome X	0.00294	0.0376	CbGeAlD
Aminosalicylic Acid—ALOX5—adipose tissue—metabolic syndrome X	0.00288	0.0368	CbGeAlD
Aminosalicylic Acid—PTGS2—blood vessel—metabolic syndrome X	0.00281	0.0359	CbGeAlD
Aminosalicylic Acid—MPO—cardiovascular system—metabolic syndrome X	0.00277	0.0354	CbGeAlD
Aminosalicylic Acid—MPO—kidney—metabolic syndrome X	0.00271	0.0346	CbGeAlD
Aminosalicylic Acid—ALOX5—liver—metabolic syndrome X	0.00202	0.0258	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Metformin—metabolic syndrome X	0.00198	0.0539	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PPARG—metabolic syndrome X	0.00192	0.333	CrCbGaD
Aminosalicylic Acid—MPO—liver—metabolic syndrome X	0.00171	0.0219	CbGeAlD
Aminosalicylic Acid—Abdominal distension—Metformin—metabolic syndrome X	0.00168	0.0458	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00146	0.0398	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Metformin—metabolic syndrome X	0.00134	0.0364	CcSEcCtD
Aminosalicylic Acid—PTGS1—cardiovascular system—metabolic syndrome X	0.00131	0.0168	CbGeAlD
Aminosalicylic Acid—PTGS1—kidney—metabolic syndrome X	0.00128	0.0164	CbGeAlD
Aminosalicylic Acid—PTGS2—cardiovascular system—metabolic syndrome X	0.00125	0.016	CbGeAlD
Aminosalicylic Acid—PTGS2—kidney—metabolic syndrome X	0.00123	0.0157	CbGeAlD
Aminosalicylic Acid—Malnutrition—Metformin—metabolic syndrome X	0.00116	0.0317	CcSEcCtD
Aminosalicylic Acid—PTGS1—adipose tissue—metabolic syndrome X	0.00116	0.0148	CbGeAlD
Aminosalicylic Acid—Flatulence—Metformin—metabolic syndrome X	0.00115	0.0312	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Metformin—metabolic syndrome X	0.00114	0.031	CcSEcCtD
Aminosalicylic Acid—PTGS2—adipose tissue—metabolic syndrome X	0.00111	0.0141	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—metabolic syndrome X	0.00103	0.179	CrCbGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000983	0.0268	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Metformin—metabolic syndrome X	0.00093	0.0254	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Metformin—metabolic syndrome X	0.000929	0.0253	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Metformin—metabolic syndrome X	0.000922	0.0251	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—metabolic syndrome X	0.00092	0.16	CrCbGaD
Aminosalicylic Acid—Anorexia—Metformin—metabolic syndrome X	0.000904	0.0247	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Metformin—metabolic syndrome X	0.000825	0.0225	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000819	0.0223	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—metabolic syndrome X	0.000811	0.14	CrCbGaD
Aminosalicylic Acid—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000776	0.0212	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—metabolic syndrome X	0.000776	0.00991	CbGeAlD
Aminosalicylic Acid—Urticaria—Metformin—metabolic syndrome X	0.000754	0.0206	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Metformin—metabolic syndrome X	0.00075	0.0205	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Metformin—metabolic syndrome X	0.000649	0.0177	CcSEcCtD
Aminosalicylic Acid—Dizziness—Metformin—metabolic syndrome X	0.000627	0.0171	CcSEcCtD
Aminosalicylic Acid—Vomiting—Metformin—metabolic syndrome X	0.000603	0.0165	CcSEcCtD
Aminosalicylic Acid—Rash—Metformin—metabolic syndrome X	0.000598	0.0163	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Metformin—metabolic syndrome X	0.000598	0.0163	CcSEcCtD
Aminosalicylic Acid—Headache—Metformin—metabolic syndrome X	0.000594	0.0162	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—metabolic syndrome X	0.000575	0.0996	CrCbGaD
Aminosalicylic Acid—Nausea—Metformin—metabolic syndrome X	0.000564	0.0154	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—metabolic syndrome X	0.000512	0.0887	CrCbGaD
Aminosalicylic Acid—ALOX5—Metabolism—GGT1—metabolic syndrome X	8.22e-05	0.000328	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GOT1—metabolic syndrome X	8.22e-05	0.000328	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD36—metabolic syndrome X	8.16e-05	0.000326	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	8.14e-05	0.000325	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	8.07e-05	0.000322	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	8e-05	0.000319	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—metabolic syndrome X	7.94e-05	0.000317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD36—metabolic syndrome X	7.84e-05	0.000313	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—metabolic syndrome X	7.82e-05	0.000312	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	7.79e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—metabolic syndrome X	7.75e-05	0.000309	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—metabolic syndrome X	7.66e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NAMPT—metabolic syndrome X	7.62e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GCK—metabolic syndrome X	7.57e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	7.56e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—metabolic syndrome X	7.53e-05	0.000301	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOC3—metabolic syndrome X	7.52e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—metabolic syndrome X	7.52e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—metabolic syndrome X	7.46e-05	0.000298	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—metabolic syndrome X	7.43e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—metabolic syndrome X	7.39e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—FABP4—metabolic syndrome X	7.39e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—metabolic syndrome X	7.36e-05	0.000294	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	7.36e-05	0.000294	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—metabolic syndrome X	7.35e-05	0.000294	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—EPHX2—metabolic syndrome X	7.34e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MLXIPL—metabolic syndrome X	7.34e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—metabolic syndrome X	7.33e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—metabolic syndrome X	7.25e-05	0.000289	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—metabolic syndrome X	7.21e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—metabolic syndrome X	7.17e-05	0.000286	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CYBA—metabolic syndrome X	7.12e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—metabolic syndrome X	7.03e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HSD11B1—metabolic syndrome X	7e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOB—metabolic syndrome X	6.97e-05	0.000278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HMGA1—metabolic syndrome X	6.92e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—metabolic syndrome X	6.92e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—metabolic syndrome X	6.92e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	6.92e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—G6PC2—metabolic syndrome X	6.9e-05	0.000275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—metabolic syndrome X	6.89e-05	0.000275	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—metabolic syndrome X	6.86e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—metabolic syndrome X	6.85e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HDAC3—metabolic syndrome X	6.83e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—metabolic syndrome X	6.82e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—metabolic syndrome X	6.8e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	6.79e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—metabolic syndrome X	6.79e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PLA2G4A—metabolic syndrome X	6.78e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—metabolic syndrome X	6.77e-05	0.00027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	6.69e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—LPL—metabolic syndrome X	6.66e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GOT2—metabolic syndrome X	6.61e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	6.6e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CYBA—metabolic syndrome X	6.58e-05	0.000263	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	6.56e-05	0.000262	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	6.48e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IRS1—metabolic syndrome X	6.42e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—metabolic syndrome X	6.38e-05	0.000255	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	6.38e-05	0.000255	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—metabolic syndrome X	6.38e-05	0.000255	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	6.35e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CD36—metabolic syndrome X	6.33e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—metabolic syndrome X	6.33e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	6.27e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—G6PD—metabolic syndrome X	6.24e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—metabolic syndrome X	6.24e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—IRS1—metabolic syndrome X	6.17e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	6.16e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	6.13e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTNR1B—metabolic syndrome X	6.1e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HDAC3—metabolic syndrome X	6.09e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	6.01e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPA—metabolic syndrome X	5.96e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCKR—metabolic syndrome X	5.96e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TRIB3—metabolic syndrome X	5.95e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RBP4—metabolic syndrome X	5.95e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—G6PD—metabolic syndrome X	5.92e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—metabolic syndrome X	5.91e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC2A4—metabolic syndrome X	5.89e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARA—metabolic syndrome X	5.88e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FABP4—metabolic syndrome X	5.87e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—VCAM1—metabolic syndrome X	5.79e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HDAC3—metabolic syndrome X	5.78e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G6—metabolic syndrome X	5.77e-05	0.00023	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	5.73e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA5—metabolic syndrome X	5.71e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GOT1—metabolic syndrome X	5.7e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AGT—metabolic syndrome X	5.7e-05	0.000227	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—metabolic syndrome X	5.67e-05	0.000226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	5.65e-05	0.000226	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GCKR—metabolic syndrome X	5.65e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—metabolic syndrome X	5.58e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HSD11B1—metabolic syndrome X	5.56e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	5.55e-05	0.000221	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOA1—metabolic syndrome X	5.52e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	5.43e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	5.39e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	5.37e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TRIB3—metabolic syndrome X	5.31e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOC3—metabolic syndrome X	5.27e-05	0.00021	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	5.24e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	5.15e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	5.12e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL18—metabolic syndrome X	5.12e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TRIB3—metabolic syndrome X	5.03e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RBP4—metabolic syndrome X	5.03e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—G6PD—metabolic syndrome X	4.96e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—metabolic syndrome X	4.9e-05	0.000196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	4.89e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—metabolic syndrome X	4.86e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOB—metabolic syndrome X	4.84e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HDAC3—metabolic syndrome X	4.84e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	4.79e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	4.78e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—INS—metabolic syndrome X	4.77e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NAMPT—metabolic syndrome X	4.76e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2C—metabolic syndrome X	4.76e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD36—metabolic syndrome X	4.75e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	4.73e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LIPC—metabolic syndrome X	4.73e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCK—metabolic syndrome X	4.73e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPA—metabolic syndrome X	4.73e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCKR—metabolic syndrome X	4.73e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—metabolic syndrome X	4.71e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOC3—metabolic syndrome X	4.7e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LPL—metabolic syndrome X	4.62e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CYBA—metabolic syndrome X	4.61e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G6—metabolic syndrome X	4.58e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CETP—metabolic syndrome X	4.56e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	4.55e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA5—metabolic syndrome X	4.53e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NAMPT—metabolic syndrome X	4.51e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GHRL—metabolic syndrome X	4.51e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GCK—metabolic syndrome X	4.48e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOC3—metabolic syndrome X	4.46e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	4.4e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—metabolic syndrome X	4.37e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SCARB1—metabolic syndrome X	4.37e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—metabolic syndrome X	4.35e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	4.31e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—metabolic syndrome X	4.29e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR1—metabolic syndrome X	4.27e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	4.26e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.26e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SREBF1—metabolic syndrome X	4.24e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TRIB3—metabolic syndrome X	4.21e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—metabolic syndrome X	4.18e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GOT2—metabolic syndrome X	4.13e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMGCR—metabolic syndrome X	4.13e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HMGA1—metabolic syndrome X	4.1e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GOT2—metabolic syndrome X	3.91e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CYBA—metabolic syndrome X	3.9e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—metabolic syndrome X	3.87e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOA1—metabolic syndrome X	3.83e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—metabolic syndrome X	3.82e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NAMPT—metabolic syndrome X	3.78e-05	0.000151	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	3.76e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCK—metabolic syndrome X	3.76e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LIPC—metabolic syndrome X	3.76e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS1—metabolic syndrome X	3.74e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOC3—metabolic syndrome X	3.73e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.72e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCA1—metabolic syndrome X	3.68e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A4—metabolic syndrome X	3.68e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CETP—metabolic syndrome X	3.62e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GOT1—metabolic syndrome X	3.56e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GGT1—metabolic syndrome X	3.56e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.56e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—metabolic syndrome X	3.49e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A4—metabolic syndrome X	3.49e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SCARB1—metabolic syndrome X	3.47e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS1—metabolic syndrome X	3.45e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOB—metabolic syndrome X	3.39e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	3.38e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GOT1—metabolic syndrome X	3.38e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SREBF1—metabolic syndrome X	3.37e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL5—metabolic syndrome X	3.31e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—INS—metabolic syndrome X	3.31e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLA2G4A—metabolic syndrome X	3.3e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMGCR—metabolic syndrome X	3.28e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GOT2—metabolic syndrome X	3.28e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LPL—metabolic syndrome X	3.24e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—metabolic syndrome X	3.04e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOB—metabolic syndrome X	3.02e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	2.94e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCA1—metabolic syndrome X	2.92e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	2.92e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—metabolic syndrome X	2.9e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPL—metabolic syndrome X	2.89e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOB—metabolic syndrome X	2.87e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GGT1—metabolic syndrome X	2.83e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GOT1—metabolic syndrome X	2.83e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGT—metabolic syndrome X	2.77e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD36—metabolic syndrome X	2.74e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LPL—metabolic syndrome X	2.74e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—metabolic syndrome X	2.71e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—metabolic syndrome X	2.71e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—metabolic syndrome X	2.69e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOA1—metabolic syndrome X	2.68e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—metabolic syndrome X	2.65e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARA—metabolic syndrome X	2.55e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—metabolic syndrome X	2.48e-05	9.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGT—metabolic syndrome X	2.47e-05	9.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—metabolic syndrome X	2.42e-05	9.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS1—metabolic syndrome X	2.42e-05	9.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOB—metabolic syndrome X	2.4e-05	9.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA1—metabolic syndrome X	2.39e-05	9.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—metabolic syndrome X	2.38e-05	9.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	2.34e-05	9.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INS—metabolic syndrome X	2.32e-05	9.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—metabolic syndrome X	2.29e-05	9.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPL—metabolic syndrome X	2.29e-05	9.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—metabolic syndrome X	2.28e-05	9.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOA1—metabolic syndrome X	2.27e-05	9.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—metabolic syndrome X	2.24e-05	8.95e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD36—metabolic syndrome X	2.18e-05	8.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—metabolic syndrome X	2.13e-05	8.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—metabolic syndrome X	2.11e-05	8.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INS—metabolic syndrome X	2.07e-05	8.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS1—metabolic syndrome X	2.05e-05	8.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—metabolic syndrome X	2.03e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARA—metabolic syndrome X	2.02e-05	8.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGT—metabolic syndrome X	1.96e-05	7.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—INS—metabolic syndrome X	1.96e-05	7.82e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—metabolic syndrome X	1.92e-05	7.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—metabolic syndrome X	1.92e-05	7.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—metabolic syndrome X	1.92e-05	7.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA1—metabolic syndrome X	1.9e-05	7.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—metabolic syndrome X	1.9e-05	7.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—metabolic syndrome X	1.81e-05	7.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—metabolic syndrome X	1.8e-05	7.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—metabolic syndrome X	1.72e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—metabolic syndrome X	1.67e-05	6.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—metabolic syndrome X	1.66e-05	6.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INS—metabolic syndrome X	1.64e-05	6.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—metabolic syndrome X	1.57e-05	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—metabolic syndrome X	1.5e-05	6.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—metabolic syndrome X	1.45e-05	5.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—metabolic syndrome X	1.44e-05	5.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—metabolic syndrome X	1.44e-05	5.75e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—metabolic syndrome X	1.34e-05	5.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—metabolic syndrome X	1.33e-05	5.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—metabolic syndrome X	1.14e-05	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—metabolic syndrome X	1.01e-05	4.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—metabolic syndrome X	9.34e-06	3.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—metabolic syndrome X	8.56e-06	3.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—metabolic syndrome X	8.33e-06	3.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—metabolic syndrome X	7.9e-06	3.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—metabolic syndrome X	6.62e-06	2.64e-05	CbGpPWpGaD
